Delivery Order SPE2DB22D9239-SPE2DB24FDE00

Award Date 10/27/23
Potential Completion Date 10/30/23
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifteen thousand two hundred twenty-one dollars and ninety-seven cents ($15,221.97) by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to provide Cabometyx 40 mg tablets, 30 count per package. The place of performance is Park Ridge, Illinois and the completion date is November 14, 2023. DMS Pharmaceutical Group Inc. will fulfill this requirement as the prime contractor. No...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty thousand three hundred forty-six dollars and sixty-four cents ($30,346.64) by the Defense Logistics Agency to provide Cabometyx 60 mg tablets. The order was awarded on November 27, 2023 and is to be completed by November 28, 2023. DMS Pharmaceutical Group will supply the pharmaceutical items to the Defense Logistics Agency under an existing indefinite delivery contract with no set-aside...
DMS Pharmaceutical Group Inc. was awarded a $30,346.64 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical contract vehicle to supply Cabometyx 60 mg tablets. The order is for 30 tablets and delivery is required by October 11, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical commodities. No set-aside provision was applied to this order, which will be fulfilled from DMS...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $15,221.97 under an indefinite delivery contract with the Defense Logistics Agency to supply Cabometyx 40 mg tablets. As a woman-owned small business, DMS Pharmaceutical Group will deliver 30 tablets of Cabometyx to the Park Ridge, Illinois location of the Defense Logistics Agency Troop Support Medical by November 9, 2023. DMS Pharmaceutical Group currently supplies pharmaceuticals and medical products in...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty thousand three hundred forty-six dollars and sixty-four cents ($30,346.64) by the Defense Logistics Agency Troop Support Medical to provide Cabometyx 60 mg tablets. The order was awarded on November 21, 2023 and is to be completed by November 22, 2023. DMS Pharmaceutical Group will deliver the pharmaceutical products to the place of performance in Park Ridge, Illinois under the terms of the delivery...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $15,173.31 by the Defense Logistics Agency Troop Support Medical to provide Cabometyx 60 mg tablets. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025. Under the indefinite delivery contract, DMS Pharmaceutical Group supplies various pharmaceutical...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifteen thousand three hundred ten dollars and eighty-three cents ($15,310.83) by the Defense Logistics Agency Troop Support Medical. This order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to military treatment facilities supported by the Defense Logistics Agency. Under this delivery order, DMS...
The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical drug CABOMETYX 20 MG TABLET 30S. The total potential value of the order is $15,596.22, with a completion date of January 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that supplies a wide range of pharmaceutical and medical products to the federal government, particularly the Department of Defense,...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $15,221.97 contract was awarded by the Defense Logistics Agency (DLA) to supply the drug CABOMETYX 40 MG TABLET 30S. This delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products for military health facilities...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifteen thousand two hundred twenty-one dollars and ninety-seven cents ($15,221.97) to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for thirty (30) 40mg tablets of Cabometyx to be delivered by October 18, 2023 in support of the Agency's pharmaceutical procurement programs. No set-aside designation was applied to this award placed under an existing pharmaceutical supply vehicle. DMS...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDE00
    Delivery Order

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Cabometyx 60 mg tablets. The $30,346.64 order calls for 30 tablets to be delivered by October 30, 2023 to the Park Ridge, Illinois location. No set-aside designation was used for this order issued against DMS Pharmaceutical Group's existing pharmaceutical prime vendor contract vehicle with the DLA, which has a potential value of up to $5 million through December 2025. As a leading pharmaceutical wholesaler, DMS will supply the prescription medication to support military treatment pharmacies globally.

Generated 1/26/24, 9:57 AM